OCI NV (OCI.AS)

NL0010558797 - Common Stock

24.8  -0.11 (-0.44%)

Fundamental Rating

2

Overall OCI gets a fundamental rating of 2 out of 10. We evaluated OCI against 65 industry peers in the Chemicals industry. OCI has a bad profitability rating. Also its financial health evaluation is rather negative. OCI is valued correctly, but it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

OCI had positive earnings in the past year.
OCI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
Of the past 5 years OCI 4 years had a positive operating cash flow.

1.2 Ratios

OCI's Return On Assets of -1.72% is on the low side compared to the rest of the industry. OCI is outperformed by 71.43% of its industry peers.
OCI's Return On Equity of -13.01% is on the low side compared to the rest of the industry. OCI is outperformed by 77.78% of its industry peers.
OCI's Return On Invested Capital of 13.96% is amongst the best of the industry. OCI outperforms 93.65% of its industry peers.
Industry RankSector Rank
ROA -1.72%
ROE -13.01%
ROIC 13.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Operating Margin of OCI (11.21%) is better than 80.95% of its industry peers.
OCI's Gross Margin of 17.57% is on the low side compared to the rest of the industry. OCI is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
OM 11.21%
PM (TTM) N/A
GM 17.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

OCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
There is no outstanding debt for OCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

OCI has an Altman-Z score of 1.43. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
OCI has a Altman-Z score of 1.43. This is in the lower half of the industry: OCI underperforms 76.19% of its industry peers.
OCI has a debt to FCF ratio of 9.60. This is a negative value and a sign of low solvency as OCI would need 9.60 years to pay back of all of its debts.
OCI has a Debt to FCF ratio (9.60) which is in line with its industry peers.
OCI has a Debt/Equity ratio of 3.30. This is a high value indicating a heavy dependency on external financing.
OCI's Debt to Equity ratio of 3.30 is on the low side compared to the rest of the industry. OCI is outperformed by 96.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF 9.6
Altman-Z 1.43
ROIC/WACC2.24
WACC6.23%

2.3 Liquidity

OCI has a Current Ratio of 1.11. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.11, OCI is doing worse than 85.71% of the companies in the same industry.
OCI has a Quick Ratio of 1.11. This is a bad value and indicates that OCI is not financially healthy enough and could expect problems in meeting its short term obligations.
OCI has a worse Quick ratio (0.98) than 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.98

2

3. Growth

3.1 Past

OCI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.76%.
OCI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.55%.
The Revenue has been decreasing by -9.61% on average over the past years.
EPS 1Y (TTM)-94.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-136.96%
Revenue 1Y (TTM)-25.55%
Revenue growth 3Y-17.33%
Revenue growth 5Y-9.61%
Revenue growth Q2Q-37%

3.2 Future

Based on estimates for the next years, OCI will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.32% on average per year.
OCI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.23% yearly.
EPS Next Y186.84%
EPS Next 2Y90.04%
EPS Next 3Y58.61%
EPS Next 5Y19.32%
Revenue Next Year-14.72%
Revenue Next 2Y-5.96%
Revenue Next 3Y-6.06%
Revenue Next 5Y2.23%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

OCI is valuated quite expensively with a Price/Earnings ratio of 67.03.
Based on the Price/Earnings ratio, OCI is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of OCI to the average of the S&P500 Index (25.20), we can say OCI is valued expensively.
OCI is valuated quite expensively with a Price/Forward Earnings ratio of 39.48.
66.67% of the companies in the same industry are cheaper than OCI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.63, OCI is valued quite expensively.
Industry RankSector Rank
PE 67.03
Fwd PE 39.48

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OCI indicates a rather cheap valuation: OCI is cheaper than 88.89% of the companies listed in the same industry.
OCI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. OCI is cheaper than 79.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.42
EV/EBITDA 4.67

4.3 Compensation for Growth

OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 58.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y90.04%
EPS Next 3Y58.61%

0

5. Dividend

5.1 Amount

OCI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OCI NV

AMS:OCI (4/25/2024, 7:00:00 PM)

24.8

-0.11 (-0.44%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.23B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 67.03
Fwd PE 39.48
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.36
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.72%
ROE -13.01%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.21%
PM (TTM) N/A
GM 17.57%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 3.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 0.98
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-94.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y186.84%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.55%
Revenue growth 3Y-17.33%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y